Allegion vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 70)

Allegion

LeaderManufacturing

Enterprise

Dublin physical security and access control (NYSE: ALLE) at $3.8B 2024 revenue; Q2 2025 record $1B+ quarterly with Salto Systems and Gatewise acquisitions expanding electronic access competing with ASSA ABLOY for global door security.

AI VisibilityBeta
Overall Score
B70
Category Rank
#18 of 290
AI Consensus
54%
Trend
stable
Per Platform
ChatGPT
62
Perplexity
68
Gemini
80

About

Allegion plc is a Dublin, Ireland-headquartered global security products company — publicly traded on the New York Stock Exchange (NYSE: ALLE) as an S&P 500 component — generating $3.8 billion in revenue in 2024 and setting a quarterly revenue record exceeding $1 billion in Q2 2025 for the first time in company history, with approximately 14,400 employees across operations in 130+ countries. Allegion's portfolio spans 25+ brands including Schlage (US residential and commercial locks), Von Duprin (exit devices since 1908), LCN (door closers since 1876), CISA (European locks), SimonsVoss (wireless electronic locking), and Interflex (workforce management). The company generates 75%+ of sales in the United States. CEO John H. Stone. Allegion was spun off from Ingersoll Rand on December 1, 2013, joining the NYSE and S&P 500 on the same day. Recent acquisitions include Salto Systems (2024, cloud-connected access control), Gatewise (2025, multifamily access control), and ELATEC (2025 pending, RFID/NFC reader technology).

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

70
Overall Score
90
#18
Category Rank
#9
54
AI Consensus
60
stable
Trend
stable
62
ChatGPT
99
68
Perplexity
99
80
Gemini
83
68
Claude
96
61
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.